It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.

A Maryland mom got diagnosed with a condition she didn’t know she had. Then she couldn’t afford the medicine. Now, state ...

Why, Naroff asks, would the White House upend the international trade structure by going after our closest trading partners?

Amgen's dividend yield remains attractive, with a moderate payout ratio and strong free cash flow. Click here to see why AMGN ...

Rep. Cory Mills, R-Fla., joins ‘The Evening Edit’ to discuss Attoney General Pam Bondi’s directives and President Donald ...

France is launching a campaign against drug use and trafficking amid record cocaine seizures and deadly shootings.

Senate and House committees both heard hourslong arguments on bills to give the Prescription Drug Affordability Board more ...

There’s an ongoing push to improve health care affordability and reduce out-of-pocket costs, especially for prescription ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

The Trump Administration's 10% tariff on all Chinese imports took effect on Feb. 4. Many unknowns remain, but Americans will ...

Drugmakers offer “copay assistance programs” to help people afford expensive medicines. But health insurers are milking these ...

A Wisconsin couple is suing Walgreens and a pharmacy benefits management company, alleging that their son died because he ...